Also trades as: 0KSX.L (LSE) · $vol 0M
DGX NYSE
Quest Diagnostics Incorporated
1W: +2.3%
1M: +2.5%
3M: +3.1%
YTD: +40.2%
1Y: +33.1%
3Y: +104.0%
5Y: +80.3%
$242.56
-0.39 (-0.16%)
Weekly Expected Move ±2.8%
$228
$235
$242
$249
$255
Credit Risk of going bust: lower than 83% of companies Debt: 19.0% of company value Bonds: $173.4M held by 208 funds, 54 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $3.08 (down 99%), Quest Diagnostics Incorporated would be worth roughly what it owes.
Total debt $6.29B against a stock market value of $26.77B.
Distance to default 10.60 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $3.24B (short-term plus half of long-term), stock volatility 23.6%; Altman Z'' 4.04. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $3.08 (down 99%), Quest Diagnostics Incorporated would be worth roughly what it owes.
Total debt $6.29B against a stock market value of $26.77B.
Distance to default 10.60 (Merton model): prices to 2026-10-27, balance sheet 2026-09-30, debt counted $3.24B (short-term plus half of long-term), stock volatility 23.6%; Altman Z'' 4.04. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
0.90
Bullish
2 bullish
0 neutral
0 bearish
Articles (24h)
2
Hourly Sentiment (24h)
0.78
Bullish
13 bullish
2 neutral
0 bearish
Articles (7d)
15
Daily Sentiment (7 Days)
Articles (100)
Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Quest Diagnostics Incorporated $DGX Stock: Yousif Capital Management LLC Raises Holdings
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
Western Digital's Q1 Earnings & Revenues Beat, Dividend Hiked by 17%
Quest Diagnostics: 3 Key Takeaways for Long-Term Investors
Quest Diagnostics (DGX) Q3 2026 Earnings Call Transcript
Quest Diagnostics outlines $12.065B-$12.105B 2026 revenue outlook while projecting consumer health growth to exceed 30%
DGX Q3 Earnings & Revenues Beat, '26 View Raised, Stock Down in Pre-Market
Quest Diagnostics boosts 2026 revenue, EPS guidance
Quest Diagnostics (DGX) Q3 Earnings and Revenues Beat Estimates
Quest Diagnostics Non-GAAP EPS of $3.00 beats by $0.13, revenue of $3.1B beats by $50M
Here are the major earnings before the open Thursday
Quest Diagnostics Q3 2026 Earnings Preview
17,683 Shares of Quest Diagnostics Incorporated $DGX Bought by CWA Asset Management Group LLC
Goldman's defensive stocks with quality-growth characteristics
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
These healthcare stocks have the highest EPS revision grade ahead of Q3 results
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Quest Diagnostics Incorporated $DGX Stock Holdings Lifted by Eastern Bank
Beat the Market Like Zacks: Thermo Fisher, Cricut, Shopify in Focus
Notable healthcare headlines for the week: Eli Lilly, Novo Nordisk, and Centene in focus
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Labcorp reaffirms long-term outlook despite preliminary CMS payment cuts
Why Quest Diagnostics Holdings Stock Dropped Today
Quest Diagnostics Study Finds High Tick-Borne Disease Co-Exposure
Is This the Right Time to Add DGX Stock to Your Portfolio?
At a glance: stocks gapping down premarket
Biggest stock movers Tuesday: UBS, VICR, and more
Stock futures edge lower after Wall Street's tech-led rally
Nykredit A S Invests $6 Million in Quest Diagnostics Incorporated $DGX
Labcorp, Quest fall as CMS cuts 2027 rates for laboratory services
Beat the Market Like Zacks: PBF, Palantir, Adobe in Focus
Corient Private Wealth LP Sells 5,233 Shares of Quest Diagnostics Incorporated $DGX
Fed Hikes Interest Rates, Signals Another: 4 Low-Beta Defensive Picks
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Quest Diagnostics (DGX) is a Top-Ranked Momentum Stock: Should You Buy?
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million
Hsbc Holdings PLC Acquires 29,842 Shares of Quest Diagnostics Incorporated $DGX
Why Is DaVita HealthCare (DVA) Down 4.9% Since Last Earnings Report?
Connor Clark & Lunn Investment Management Ltd. Buys Shares of 3,113 Quest Diagnostics Incorporated $DGX
Quest Diagnostics (DGX) is a Top-Ranked Value Stock: Should You Buy?
Bank OZK Makes New Investment in Quest Diagnostics Incorporated $DGX
Chemed (CHE) Up 1.7% Since Last Earnings Report: Can It Continue?
Artia Global Partners LP Acquires New Holdings in Quest Diagnostics Incorporated $DGX
Beat the Market Like Zacks: Amgen, FirstCash, Delek in Focus
Is it the Right Time to Retain DGX Stock in Your Portfolio?
Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue?
Quest Diagnostics (DGX) Upgraded to Buy: Here's Why
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Quest Diagnostics (DGX) Is Up 2.29% in One Week: What You Should Know
HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up
National Vision Stock Down Despite Q2 Earnings & Revenue Beat
TECH Q4 Earnings Meet Estimates, Revenues Surpass, Stock Rises
Hims & Hers Stock Plunges Post Q2 Earnings Miss, Gross Margin Down
Alcon's Q2 Earnings and Revenues Surpass Estimates, Stock Climbs
Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?
PODD's Q2 Earnings Top Estimates, FY'26 Sales View Cut, Stock Down
PBH Stock Up on Q1 Earnings and Revenue Beat, Fiscal '27 View Raised
RMD Stock Down Despite Q4 Earnings Beat, Revenues Rise Y/Y
Labcorp Stock Jumps 14% in a Month as Growth Meets Rich Valuation
BD Stock Up in Pre-Market Post Q3 Earnings & Revenue Beat, Margins Down
STE Q1 Earnings Beat, Revenues Miss, Stock Dips in Aftermarket Trading
DaVita Stock Down in Pre-Market Despite Q2 Earnings Beat, Margins Down
ZBH's Q2 Earnings Beat, '26 View Raised, Stock Up in Pre-Market
CRL Q2 Earnings and Revenues Top, '26 View Up, Stock Up in Pre-Market
CVS Health Q2 Earnings and Revenues Top Estimates, Stock Climbs
IDXX Q2 Earnings & Revenues Beat, '26 EPS View Up, Stock Up in Pre-Market
HSIC Surpasses Q2 Earnings and Revenue Estimates, Stock Climbs
Quest Diagnostics Raises 2026 Outlook as Testing Demand Accelerates
Beat the Market the Zacks Way: Credo, Victoria's Secret, Bank of America in Focus
Bank of America Corp DE Acquires 129,964 Shares of Quest Diagnostics Incorporated $DGX
Is DGX Stock Worth Buying After Its Strong 2026 Earnings Momentum?
Quest Diagnostics Growth Drivers Investors Should Watch Now in 2026
LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise
Here's Why Quest Diagnostics (DGX) is a Strong Value Stock
Most S&P 500 stocks trade above 50-day moving average for first time since February
Why Quest Diagnostics Stock Climbed This Past Week
Notable healthcare headlines for the week: Eli Lilly, Molina Healthcare, and Roche in focus
Are You Looking for a Top Momentum Pick? Why Quest Diagnostics (DGX) is a Great Choice
Why Quest Diagnostics (DGX) is a Top Momentum Stock for the Long-Term
Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out?
Are Medical Stocks Lagging Corcept Therapeutics (CORT) This Year?
DGX Stock Up on Q2 Earnings & Revenue Beat, '26 View Raised
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
Here are the major earnings before the open Thursday
Quest Diagnostics Incorporated $DGX Shares Purchased by ABN Amro Investment Solutions
5 High Dividend Yield Stocks to Buy for a Stable Portfolio in 2H 2026
Quest Diagnostics to Report Q2 Earnings: Key Customer Channels in Focus
Abbott's Q2 Earnings on Deck: How Should You Play the Stock Now?
Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock
Beat the Market the Zacks Way: PDF Solutions, LifeStance Health, Paychex in Focus
Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run?
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year?
How Abbott's Largest Segment Is Preparing for the Next Growth Phase
DGX's Stock Rises on Haystack MRD Test's Approval From NYSDOH
Is it Apt to Hold Quest Diagnostics Stock in Your Portfolio Now?
Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock